Jeffery Ardinger

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Production of large quantities of viral vectors is crucial for the success of gene therapy in the clinic. There is a need for higher titers of herpes simplex virus-1 (HSV-1) vectors both for therapeutic use as well as in the manufacturing of clinical grade adeno-associated virus (AAV) vectors. HSV-1 yield increased when primary human fibroblasts were(More)
  • 1